Login
Rafael Holdings NYSE: RFL
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
| Name | Rafael Holdings |
| Ticker | RFL |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
|
Price
52W Low/High |
51.63
13.66 / 63.59 |
| Momentum | Neutral |
| Market cap | 817 M |
| 1Y Total Return |
277.96 %
Strong |
| 1Y Volatility |
71.37 %
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
Details
| Ticker | RFL |
| Name | Rafael Holdings |
| ISIN | US75062E1064 |
| CUSIP | 75062E106 |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 07/23/2021
| Close Price | 51.63 |
| 52W Low/High | 13.66 / 63.59 |
| Market cap | 817 M |
| 1Y Total Return |
277.96 %
Strong |
| 1Y Volatility |
71.37 %
High Risk |
| Beta | 3.14 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -383.7 % |
| Cash from Op. / Cur. Liabilities | -0.77 |
| Diluted Earnings / Share | -1.07 |
| ROE | - |
| ROIC | -13.4 % |
| Price / Revenue | 186.5 |
| Price / Book | 6.9 |
| Price / CF | -100.7 |
| Current Ratio | 0.6 |
| Cur.Liabilities / Tot.Liabilities | 1.0 |
| Financial Leverage | 0.00 |
| in Mils USD |
rolling-year up to December
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
4
|
5
|
4
|
5
|
|
| Gross Profit |
4
|
5
|
4
|
5
|
|
| R&D |
4
|
1
|
2
|
0
|
|
| EBITDA |
-15
|
-4
|
-2
|
0
|
|
| Operating Income |
-18
|
-8
|
-4
|
-2
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
16
|
16
|
13
|
13
|
|
| EPS exc. Extra |
-1.07
|
-0.41
|
-0.26
|
-0.80
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
146
|
139
|
144
|
78
|
|
| Cash, Eq & Invt ShortTerm |
6
|
10
|
15
|
12
|
|
| Total Current Assets |
7
|
10
|
16
|
12
|
|
| Total Non-Current Assets |
140
|
129
|
128
|
65
|
|
| Intangibles |
2
|
2
|
0
|
0
|
|
| Total Liabilities |
11
|
1
|
16
|
25
|
|
| Total Current Liabilities |
11
|
1
|
1
|
1
|
|
| Long Term Debt |
0
|
0
|
15
|
24
|
|
| Shareholder equity |
121
|
124
|
119
|
43
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-8
|
-4
|
-3
|
-1
|
|
| Depreciation |
2
|
2
|
2
|
2
|
|
| Cash from Investing |
-9
|
-1
|
-26
|
-3
|
|
| Capex |
3
|
1
|
0
|
1
|
|
| Cash from Financing |
14
|
-0
|
32
|
4
|
|
| Stock Issued |
13
|
-0
|
9
|
0
|
|
| Debt (LT) Issued |
0
|
0
|
18
|
0
|
|
| Free Cash Flow |
-9
|
-5
|
-2
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
0.6
|
8.6
|
13.0
|
23.4
|
|
| Financial Leverage D/E |
0.00
|
0.00
|
0.13
|
0.00
|
|
| Return on Capital Avg |
-13.4 %
|
-4.4 %
|
-4.3 %
|
-30.8 %
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available